Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma. [electronic resource]
Producer: 20010322Description: 1471-6 p. digitalISSN:- 0923-7534
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Administration, Oral
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Arrhythmias, Cardiac -- chemically induced
- Biological Transport -- drug effects
- Breast Neoplasms -- drug therapy
- Calcium Channel Blockers -- adverse effects
- Cohort Studies
- Disease-Free Survival
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Fluorouracil -- administration & dosage
- Gastrointestinal Diseases -- chemically induced
- Humans
- Life Tables
- Middle Aged
- Neoplasm Proteins -- antagonists & inhibitors
- Prospective Studies
- Survival Analysis
- Treatment Outcome
- Verapamil -- adverse effects
- Vindesine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.